BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38392067)

  • 21. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.
    Jauhari Y; Gannon MR; Tsang C; Horgan K; Dodwell D; Clements K; Medina J; Tang S; Pettengell R; Cromwell DA
    Eur J Surg Oncol; 2019 Aug; 45(8):1378-1387. PubMed ID: 30878169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
    Hahn E; Rodin D; Sutradhar R; Nofech-Mozes S; Trebinjac S; Paszat LF; Rakovitch E
    Curr Oncol; 2023 Jun; 30(6):5795-5806. PubMed ID: 37366916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
    Alvarado M; Carter DL; Guenther JM; Hagans J; Lei RY; Leonard CE; Manders J; Sing AP; Broder MS; Cherepanov D; Chang E; Eagan M; Hsiao W; Schultz MJ
    J Surg Oncol; 2015 Jun; 111(8):935-40. PubMed ID: 26031501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
    Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
    Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal carcinoma in situ: treatment or active surveillance?
    Kuerer HM
    Expert Rev Anticancer Ther; 2015; 15(7):777-85. PubMed ID: 25938920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
    Fisher B; Land S; Mamounas E; Dignam J; Fisher ER; Wolmark N
    Semin Oncol; 2001 Aug; 28(4):400-18. PubMed ID: 11498833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.
    De Morgan S; Redman S; White KJ; Cakir B; Boyages J
    Health Expect; 2002 Dec; 5(4):310-8. PubMed ID: 12460220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing.
    Fridman I; Chan L; Thomas J; Fish LJ; Falkovic M; Brioux J; Hunter N; Ryser DH; Hwang ES; Pollak KI; Weinfurt KP; Ryser MD
    Breast Cancer Res Treat; 2022 Apr; 192(3):517-527. PubMed ID: 35107714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS).
    De Morgan SE; Butow PN; Lobb EA; Price MA; Nehill C
    Support Care Cancer; 2011 May; 19(5):717-23. PubMed ID: 21088858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?
    Rosso KJ; Weiss A; Thompson AM
    Surg Oncol Clin N Am; 2018 Jan; 27(1):69-80. PubMed ID: 29132566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of ductal carcinoma in situ in Australia in 1995.
    Shugg D; White VM; Kitchen PR; Pruden M; Collins JP; Hill DJ
    ANZ J Surg; 2002 Oct; 72(10):708-15. PubMed ID: 12534380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ.
    Katz SJ; Lantz PM; Janz NK; Fagerlin A; Schwartz K; Liu L; Deapen D; Salem B; Lakhani I; Morrow M
    J Clin Oncol; 2005 May; 23(13):3001-7. PubMed ID: 15860856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
    Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
    Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS).
    Kennedy F; Harcourt D; Rumsey N
    Eur J Oncol Nurs; 2008 Apr; 12(2):103-11. PubMed ID: 18023255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.
    Kaplan CP; Nápoles AM; Hwang ES; Bloom J; Stewart S; Nickleach D; Karliner L
    J Womens Health (Larchmt); 2011 Feb; 20(2):215-23. PubMed ID: 21128819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.
    Rosenberg SM; Gierisch JM; Revette AC; Lowenstein CL; Frank ES; Collyar DE; Lynch T; Thompson AM; Partridge AH; Hwang ES
    Cancer; 2022 Apr; 128(8):1676-1683. PubMed ID: 35191017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy.
    Piltin MA; Hoskin TL; Day CN; Shumway DA; Habermann EB; Davis J; Boughey JC
    Ann Surg Oncol; 2021 Aug; 28(8):4294-4303. PubMed ID: 33462716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.